EU to rule on J&J shot safety as raging Covid-19 wave grips India

The J&J vaccine concerns follow similar reports of blood clots in a very small number of people who received the AstraZeneca shot. The EMA described those clots as a "very rare" side effect, stressing that the AstraZeneca jab's benefits outweigh the risks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dvGDM8
via IFTTT